Phase II Study of Cholesterol- and Cholestanol-Free Diet, Lovastatin, and Chenodeoxycholic Acid for Cerebrotendinous Xanthomatosis - Related Studies

Phase II Study of Cholesterol- and Cholestanol-Free Diet, Lovastatin, and Chenodeoxycholic Acid for Cerebrotendinous Xanthomatosis

This study is currently recruiting participants.

Study NCT00004346. Last updated on June 23, 2005. Information provided by National Center for Research Resources (NCRR)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Cerebrotendinous Xanthomatosis

2	Additional conditions recognized in this trial
		Xanthomatosis
		Xanthomatosis, Cerebrotendinous

3	More general conditions related to this trial
		Genetic Diseases, Inborn
		Lipid Metabolism Disorders
		Lipid Metabolism, Inborn Errors
		Metabolic Diseases
		Metabolism, Inborn Errors

4	Interventions listed in this trial
		chenodeoxycholic acid
		lovastatin

5	More general drug interventions related to this trial
		Anticholesteremic Agents
		Antilipemic Agents
		Antimetabolites
		Cathartics
		Enzyme Inhibitors
		Gastrointestinal Agents
		Hydroxymethylglutaryl-CoA Reductase Inhibitors
		Molecular Mechanisms of Pharmacological Action
		Pharmacologic Actions
		Therapeutic Uses

6	Sponsors listed in this trial
		National Center for Research Resources (NCRR)
		Oregon Health and Science University